1. Intraarterial gadolinium-based contrast material
- Author
-
H Pagan-Marin, John M. Gemery, and Scott K. Reid
- Subjects
medicine.diagnostic_test ,business.industry ,media_common.quotation_subject ,Gadolinium ,Mr angiography ,chemistry.chemical_element ,Renal function ,Contrast Media ,Magnetic resonance imaging ,Body weight ,chemistry ,Injections, Intra-Arterial ,Angiography ,medicine ,Contrast (vision) ,Humans ,Radiology, Nuclear Medicine and imaging ,Nuclear medicine ,business ,Serum creatinine level ,Magnetic Resonance Angiography ,media_common - Abstract
Editor: We read with interest Dr Rofsky’s article on magnetic resonance (MR) angiography in the February 2000 issue of Radiology (1); however, we were surprised to be cited in reference to the injection of gadolinium-based contrast material into the renal arteries. In our case report, we describe worsening renal function in a patient who underwent lower-extremity gadolinium-enhanced arteriography. The patient’s baseline serum creatinine level of 4.0 mg/dL (353.6 mmol/L) increased to a peak of 9.3 mg/dL (822.1 mmol/L) after the patient received 80 mL (0.44 mmol per kilogram of body weight) of gadoliniumbased contrast material. A small point perhaps, and we certainly agree with Dr Rofsky that gadolinium-based contrast material as used in MR angiography is safe and effective.
- Published
- 2001